28.06.2023 – 17:13Helmholtz MunichNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
15.06.2023 – 09:36Berlin CuresBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in Junemore
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupOne documentmore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
28.02.2023 – 07:30Fördergesellschaft IZB mbHInnovation and Start-up Center Biotechnology (IZB) welcomes InvitrisIn the IZB you can find over 50 biotech start-upsOne documentmore
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmore
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmore
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmore
19.07.2022 – 08:00R-Biopharm AGR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratoriesmore
24.02.2022 – 16:41Fördergesellschaft IZB mbHInnovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.BioIn the IZB you can find over 50 biotech start-upsOne documentmore
18.02.2022 – 11:15EcoCare2Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomatsmore
19.01.2022 – 12:51News DirectALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERSmore
07.12.2021 – 11:41R-Biopharm AG2R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislationmore
08.11.2021 – 14:17SYNformulas GmbHCPhI worldwide: German probiotics company SYNformulas seeks partnerships to drive internationalizationmore
03.11.2021 – 14:06Fördergesellschaft IZB mbH2The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeuticsIn the IZB you can find over 50 biotech start-upsOne documentmore
20.10.2021 – 16:30Sysmex Inostics GmbHNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inosticsmore
19.08.2021 – 11:02MAHLE International GmbH6Press Release MAHLE Covid-19 worldwide vaccination initiativesmore
13.07.2021 – 15:13News DirectZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospitalmore
08.07.2021 – 12:10Fördergesellschaft IZB mbH2COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grantIn the IZB you can find over 50 biotech start-upsOne documentmore
01.07.2021 – 16:04News Direct3Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Accessmore
01.07.2021 – 06:01Fördergesellschaft IZB mbH7Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021In the IZB you can find over 50 biotech start-upsOne documentmore
27.05.2021 – 10:35BrainRepair UGInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15Mmore
25.05.2021 – 10:33nal von minden GmbHDid my vaccine work? New rapid test for the determination of vaccination successmore
13.04.2021 – 14:04Fördergesellschaft IZB mbH2Lindis Biotech develops immunotherapy against bladder cancerIn the IZB you can find over 50 biotech start-upsOne documentmore
02.03.2021 – 14:36B. Braun Melsungen AG2B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®more